Dong-A’s drug sales unlikely to top 1 trillion won
Published: 2012-11-28 07:00:00
Updated: 2012-11-28 07:00:00
Dong-A Pharmaceutical Co., Korea’s largest drug producer, is unlikely to gain its membership in the 1-trillion won seller club this year in the aftermath of the government’s forced price cut for drugs and other medical products covered by National Health Insurance.
The Seoul-based firm yesterd...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
